PT2928896T - Forma sólida de um derivado de dihidro-pirido-oxazina - Google Patents

Forma sólida de um derivado de dihidro-pirido-oxazina

Info

Publication number
PT2928896T
PT2928896T PT138241773T PT13824177T PT2928896T PT 2928896 T PT2928896 T PT 2928896T PT 138241773 T PT138241773 T PT 138241773T PT 13824177 T PT13824177 T PT 13824177T PT 2928896 T PT2928896 T PT 2928896T
Authority
PT
Portugal
Prior art keywords
pyrido
dihydro
solid form
oxazine derivative
oxazine
Prior art date
Application number
PT138241773T
Other languages
English (en)
Inventor
Soldermann Nicolas
Hurth Konstanze
Kalis Christoph
Kammertoens Karen
Zecri Frédéric
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51019963&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2928896(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT2928896T publication Critical patent/PT2928896T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT138241773T 2012-11-26 2013-11-26 Forma sólida de um derivado de dihidro-pirido-oxazina PT2928896T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GC201222895 2012-11-26
IR1391307213 2012-12-04

Publications (1)

Publication Number Publication Date
PT2928896T true PT2928896T (pt) 2017-10-25

Family

ID=51019963

Family Applications (1)

Application Number Title Priority Date Filing Date
PT138241773T PT2928896T (pt) 2012-11-26 2013-11-26 Forma sólida de um derivado de dihidro-pirido-oxazina

Country Status (23)

Country Link
EP (1) EP2928896B1 (pt)
KR (1) KR102184069B1 (pt)
CN (1) CN104870451B (pt)
AU (1) AU2013368997B8 (pt)
BR (1) BR112015009870A2 (pt)
CA (1) CA2891521A1 (pt)
CL (1) CL2015001409A1 (pt)
CY (1) CY1119702T1 (pt)
DK (1) DK2928896T3 (pt)
GT (1) GT201500124A (pt)
HK (1) HK1209419A1 (pt)
IL (1) IL238889B (pt)
MX (1) MX366342B (pt)
NZ (1) NZ706865A (pt)
PE (1) PE20150946A1 (pt)
PH (1) PH12015501052A1 (pt)
PL (1) PL2928896T3 (pt)
PT (1) PT2928896T (pt)
SG (1) SG11201503410VA (pt)
TN (1) TN2015000128A1 (pt)
TW (1) TW201422625A (pt)
WO (1) WO2014102630A1 (pt)
ZA (1) ZA201502350B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5903499B2 (ja) 2011-12-22 2016-04-13 ノバルティス アーゲー ジヒドロ−ベンゾ−オキサジンおよびジヒドロ−ピリド−オキサジン誘導体
EP3837263B1 (en) 2018-08-13 2024-07-03 F. Hoffmann-La Roche AG New heterocyclic compounds as monoacylglycerol lipase inhibitors
AU2020346350A1 (en) 2019-09-12 2022-02-17 F. Hoffmann-La Roche Ag 4,4A,5,7,8,8A-hexapyrido(4,3-b)(1,4)oxazin-3-one compounds as magl inhibitors

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU11248A1 (ru) 1927-03-29 1929-09-30 В.С. Григорьев Способ очистки антрацена
GB1524747A (en) 1976-05-11 1978-09-13 Ici Ltd Polypeptide
EP0100172B1 (en) 1982-07-23 1987-08-12 Imperial Chemical Industries Plc Amide derivatives
GB8327256D0 (en) 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
US5093330A (en) 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
US5010099A (en) 1989-08-11 1991-04-23 Harbor Branch Oceanographic Institution, Inc. Discodermolide compounds, compositions containing same and method of preparation and use
NZ243082A (en) 1991-06-28 1995-02-24 Ici Plc 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
GB9300059D0 (en) 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
TW225528B (pt) 1992-04-03 1994-06-21 Ciba Geigy Ag
GB9314893D0 (en) 1993-07-19 1993-09-01 Zeneca Ltd Quinazoline derivatives
EP3103799B1 (en) 1995-03-30 2018-06-06 OSI Pharmaceuticals, LLC Quinazoline derivatives
GB9508538D0 (en) 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
US5747498A (en) 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
US5843901A (en) 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
NZ312665A (en) 1995-07-06 1999-08-30 Novartis Ag Rrolopyrimidines(7h-pyrrolo[2,3-d]pyrimidine and preparation of these
US5760041A (en) 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
GB9603095D0 (en) 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
CN100503580C (zh) 1996-04-12 2009-06-24 沃尼尔·朗伯公司 酪氨酸激酶的不可逆抑制剂
CA2258548C (en) 1996-06-24 2005-07-26 Pfizer Inc. Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
NZ334821A (en) 1996-08-30 2000-12-22 Novartis Ag Method for producing epothilones
DE938597T1 (de) 1996-09-06 2000-03-09 Obducat Ab Verfahren für das anisotrope ätzen von strukturen in leitende materialien
CA2265630A1 (en) 1996-09-13 1998-03-19 Gerald Mcmahon Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
EP0837063A1 (en) 1996-10-17 1998-04-22 Pfizer Inc. 4-Aminoquinazoline derivatives
AU753546B2 (en) 1996-11-18 2002-10-24 Helmholtz-Zentrum Fuer Infektionsforschung Gmbh Epothilone C, D, E and F, production process, and their use as cytostatic as well as phytosanitary agents
US6441186B1 (en) 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
CO4940418A1 (es) 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
GB9721069D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Polymeric derivatives of camptothecin
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
WO1999043653A1 (en) 1998-02-25 1999-09-02 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues therof
CN1152031C (zh) 1998-08-11 2004-06-02 诺瓦提斯公司 具有血管生成抑制活性的异喹啉衍生物
KR100716272B1 (ko) 1998-11-20 2007-05-09 코산 바이오사이언시즈, 인코포레이티드 에포틸론 및 에포틸론 유도체의 생산을 위한 재조합 방법 및 물질
PE20020354A1 (es) 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
ATE445613T1 (de) 2000-11-07 2009-10-15 Novartis Pharma Gmbh Indolylmaleimidderivative als proteinkinase-c- inhibitoren
AR035885A1 (es) 2001-05-14 2004-07-21 Novartis Ag Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
GB0119249D0 (en) 2001-08-07 2001-10-03 Novartis Ag Organic compounds
TW200918046A (en) 2002-04-03 2009-05-01 Novartis Ag Indolylmaleimide derivatives
NZ540427A (en) 2002-12-09 2008-04-30 Univ Texas Methods for selectively inhibiting janus tyrosine kinase 3 (Jak3)
JP5283336B2 (ja) 2004-01-12 2013-09-04 ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド 選択的キナーゼ阻害剤
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
JP2009507072A (ja) * 2005-09-07 2009-02-19 ラボラトワール セローノ ソシエテ アノニム 子宮内膜症の処置のためのｐｉ３ｋ阻害剤
GB0620059D0 (en) * 2006-10-10 2006-11-22 Ucb Sa Therapeutic agents
JP5903499B2 (ja) * 2011-12-22 2016-04-13 ノバルティス アーゲー ジヒドロ−ベンゾ−オキサジンおよびジヒドロ−ピリド−オキサジン誘導体

Also Published As

Publication number Publication date
AU2013368997A1 (en) 2015-04-30
CN104870451A (zh) 2015-08-26
EP2928896A1 (en) 2015-10-14
CN104870451B (zh) 2017-07-07
ZA201502350B (en) 2017-08-30
PL2928896T3 (pl) 2018-01-31
SG11201503410VA (en) 2015-05-28
MX366342B (es) 2019-07-05
EP2928896B1 (en) 2017-07-19
CL2015001409A1 (es) 2015-07-24
CY1119702T1 (el) 2018-06-27
GT201500124A (es) 2016-03-01
IL238889B (en) 2021-03-25
KR20150091047A (ko) 2015-08-07
TW201422625A (zh) 2014-06-16
IL238889A0 (en) 2015-07-30
HK1209419A1 (en) 2016-04-01
PE20150946A1 (es) 2015-06-28
AU2013368997B2 (en) 2015-09-24
CA2891521A1 (en) 2014-07-03
NZ706865A (en) 2016-04-29
WO2014102630A1 (en) 2014-07-03
DK2928896T3 (da) 2017-11-06
MX2015006650A (es) 2015-08-10
TN2015000128A1 (en) 2016-10-03
KR102184069B1 (ko) 2020-11-30
BR112015009870A2 (pt) 2017-12-05
PH12015501052A1 (en) 2015-07-27
AU2013368997B8 (en) 2015-10-08
AU2013368997A8 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
HK1212701A1 (zh) 恩雜魯胺製劑
HK1207375A1 (en) Piperidinylpyrazolopyridine derivative
HK1207363A1 (en) Novel indanesulfamide derivative
EP2917314A4 (en) OLIGOMERATZUSAMMENSETZUNG
EP2800747A4 (en) POLYMORPHY OF PERAMPANEL
IL236312A0 (en) Preparation of 18f-flucyclobin
EP2881113A4 (en) NEW APPLICATION OF POGOSTONE
HK1200824A1 (en) Substituted phenylazole derivative
EP2892529A4 (en) USES OF (-) - PERHEXILINE
EP2873660A4 (en) INDOLCARBOXAMIDDERIVAT
PL2807172T3 (pl) Pochodne pirymidooksazocyny jako inhibitory mTOR
ZA201502350B (en) Solid form of hihydro-pyrido-oxazine derivative
EP2842958A4 (en) NAPHTHOBISTHIADIAZOLDERIVAT
HK1204621A1 (en) 4-alkanoylamino-3-pyrazolone derivative 4--3-
SI2928896T1 (sl) Trdna oblika derivata dihidro-pirido-oksazina
TWM433525U (en) Structure of calorifier
IL233446A0 (en) Polymorphic forms of paramphenel